Figure 5
From: Extracellular vesicles from dHL-60 cells as delivery vehicles for diverse therapeutics
The delivery of Cas 9-GFP using dHL-60 cell-derived EVs. (a) Left panels, fluorescence levels of Cas9 in the HL-60 and dHL-60 cells. Right panels, fluorescence levels of Cas9 in EVs derived from the HL-60 and dHL-60 cells. (b) Fluorescence levels of Cas9 in the MCF-7, Jurkat, and dTHP-1 cells exposed to EVs. All data represent three independent experiments; mean ± SEM. *P < 0.05; **P < 0.01.
